A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Public ClinicalTrials.gov record NCT03370133. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Study identification
- NCT ID
- NCT03370133
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- UCB Biopharma SRL
- Industry
- Enrollment
- 567 participants
Conditions and interventions
Interventions
- Bimekizumab Drug
- Placebo Other
- Ustekinumab Drug
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 5, 2017
- Primary completion
- Jan 7, 2019
- Completion
- Dec 12, 2019
- Last update posted
- Apr 14, 2026
2017 – 2019
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ps0009 946 | Phoenix | Arizona | 85032 | — |
| Ps0009 910 | Bakersfield | California | 93309 | — |
| Ps0009 919 | San Diego | California | 92103 | — |
| Ps0009 906 | Boca Raton | Florida | 33486 | — |
| Ps0009 909 | Boynton Beach | Florida | 33437 | — |
| Ps0009 912 | Coral Gables | Florida | 33134 | — |
| Ps0009 907 | Miami | Florida | 33144 | — |
| Ps0009 903 | Ocala | Florida | 34471 | — |
| Ps0009 921 | Ormond Beach | Florida | 32174 | — |
| Ps0009 918 | Tampa | Florida | 33612 | — |
| Ps0009 941 | Alpharetta | Georgia | 30022 | — |
| Ps0009 911 | Plainfield | Indiana | 46168 | — |
| Ps0009 900 | West Des Moines | Iowa | 50265 | — |
| Ps0009 905 | Overland Park | Kansas | 66215 | — |
| Ps0009 922 | Baton Rouge | Louisiana | 70809 | — |
| Ps0009 917 | Troy | Michigan | 48084 | — |
| Ps0009 915 | St Louis | Missouri | 63117 | — |
| Ps0009 958 | Omaha | Nebraska | 68144 | — |
| Ps0009 901 | Portsmouth | New Hampshire | 03801 | — |
| Ps0009 908 | East Windsor | New Jersey | 08520 | — |
| Ps0009 923 | Albuquerque | New Mexico | 87106 | — |
| Ps0009 913 | New York | New York | 10029-65 | — |
| Ps0009 920 | Portland | Oregon | 97210 | — |
| Ps0009 924 | Houston | Texas | 77004 | — |
| Ps0009 914 | San Antonio | Texas | 78213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 80 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03370133, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 14, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03370133 live on ClinicalTrials.gov.